🎉Count Your TLMs!
My first TLM was in 2018 in San Francisco. Since then, I’ve attended every year. #TLM25 will be my 8th #TLM!
TLM is where mentorships, research, and ideas grow!
👉What number TLM is this for you?
💬Share what you’re most excited about!
#AASLD@AASLDtweets
As the leader in hepatology, #AASLD is committed to evidence-based policies that protect liver health. One of the most effective tools = #hepatitisB vaccination at birth.
Congratulations to two outstanding leaders in liver and research on their endowed professorships - Neehar Parikh and @ebtapper - especially grateful to be included in the ceremony for our amazing friend @laurakulik1@docamitgs@serperm@MichiganLiver
With heavy hearts, we share the recent passing of Dr. Bruce Bacon, a leader and mentor in the field of hepatology.
Please take a moment to read a tribute, authored by AASLD Foundation Chair Dr. Kim Brown, honoring his extraordinary life and legacy: https://t.co/k6aLF5vIxD
✅ out this month’s issue‼️
Learn about:
📑 Role of muscle in MASLD❓
📑 Optimal AFP cut-off in HCC screening in cured HCV?❓
📑 Min meaningful diff in PROs in cirrhosis❓
📑 How well are we treating itch in PSC❓
📑 How best to 🔍 fibrosis in MetALD❓
https://t.co/AcRT4Itt6v
There were cheers at #TLM24 for the most anticipated RCT:
➡️72 weeks of treatment with semaglutide resulted in fibrosis improvement in 37% vs 22.5% for placebo in MASH patients!
👉 semaglutide can treat MASH & the underlying cardio metabolic profile & obesity & reduce MACE❗️
SIG and Committee nominations are open! AASLD will be accepting nominations through Friday, June 28 at 12 p.m. EDT. We invite you to participate.
View Committee Vacancies: https://t.co/wE8PVG1gbB
View SIG Vacancies: https://t.co/e8IgIUtpuK